February 19, 2026 Media Coverage from ARCH Venture Partners | Share ARCH’s Carol Suh named to National Venture Capital Association’s 2026 List of Rising Stars
January 7, 2026 Media Coverage from ARCH Venture Partners | Share D-Wave Quantum acquires ARCH-backed Quantum Circuits to accelerate the development of quantum computers
November 13, 2025 Media Coverage from ARCH Venture Partners | Share Metsera acquired by Pfizer in $10 Billion deal to accelerate obesity drug development
October 10, 2025 Media Coverage from ARCH Venture Partners | Share Bristol Myers Squibb acquires Orbital Therapeutics and its In Vivo RNA platform
September 22, 2025 Media Coverage from ARCH Venture Partners | Share ARCH’s Seaport Therapeutics included on Fierce Biotech’s 2025 Fierce 15 list of companies redefining biotech
September 19, 2025 Media Coverage from ARCH Venture Partners | Share ARCH-backed Dispatch Bio and Sironax named to Endpoints 11 list of most exciting startups in 2025
September 2, 2025 Media Coverage from ARCH Venture Partners | Share Five ARCH-backed companies and executives named to Fierce 50 list of those making a significant impact in the biopharma and healthcare industries
August 19, 2025 Media Coverage from ARCH Venture Partners | Share TIME and Statista name ARCH a top venture firm in the U.S.
July 23, 2025 Media Coverage from ARCH Venture Partners | Share ARCH-backed Dispatch Bio aims to develop a universal immunotherapy treatment
June 20, 2025 Media Coverage from ARCH Venture Partners | Share ARCH’s Keith Crandell talks biotech investing with Axios Pro
May 27, 2025 Media Coverage from ARCH Venture Partners | Share ARCH’s Bob Nelsen appears on Forbes 2025 Midas List
April 10, 2025 Media Coverage from ARCH Venture Partners | Share ARCH Co-founder and Managing Director Bob Nelsen named to STAT’s 2025 STATUS list of the most influential people shaping the health industry
